24th March 2022 | Pharma Updates

PharmaState Updates – Latest Pharma Happenings

DCGI approved the Covid-19 vaccine Covovax for phase 3 clinical trial

Drugs Controller General of India cleared the phase 3 clinical trial of Covovax, a COVID-19 vaccine, as a booster dosage in adults.

Breast cancer diagnostics will be aided by chip technology

A team of IISc scientists has now announced the development of a system for quick, label-free diagnosis for breast cancer diagnosis.

COVID-19 vaccine for children aged 6 months to 5 years submitted to FDA for clearance

Moderna said it will seek regulators to approve the COVID-19 vaccine for children under the age of six, citing immune response data from a clinical trial that was identical to that of adults.

FDA approved Novartis Pluvicto as the first targeted radioligand therapy

Pluvicto was approved by FDA today for adult patients with prostate-specific membrane antigen–positive metastatic castration-resistant prostate cancer, according to Novartis.

Artificial intelligence is being used to detect emerging pandemics

The use of artificial intelligence to filter and analyse open-source data could help prevent future infections from becoming worldwide pandemics.

Breyna has been approved by the FDA to treat asthma and COPD

The first generic of Symbicort, budesonide and formoterol fumarate dihydrate, an inhaled drug used to treat asthma and chronic obstructive pulmonary disease, has been approved by the FDA.

RINVOQ approved by the FDA for the treatment ulcerative colitis in adults

RINVOQ has been approved by the FDA as a treatment for adults with moderately to highly active ulcerative colitis who have not responded well to other treatments.

Designing first-line melanoma clinical studies after anti-LAG-3 approval: the Opdualag effect

The recent FDA approval of Opdualag, which contains relatlimab and Opdivo, is anticipated to have an impact on future data readouts and active comparator selections in trials.

Artio Medical has received FDA approval for its first medical device

Solus Gold Embolization Device, a next-generation product that can block or restrict blood flow in blood vessels, has received FDA approval from the Prairie Village-based revolutionary medical device firm.

COVID-19 instances are up for the second week in a row, but deaths are down

According to WHO, the number of new coronavirus cases worldwide climbed by 7% in the last week, owing to a rise in infections in the Western Pacific.